OPKO Health OPK
$ 1.61
2.88%
Quarterly report 2024-Q3
added 11-07-2024
OPKO Health Balance Sheet 2011-2024 | OPK
Annual Balance Sheet OPKO Health
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-75.2 M | -132 M | 82.2 M | 163 M | 184 M | 108 M | 55.3 M | -73.5 M | -58.1 M | 50.4 M | 41.9 M | -4.68 M | -62.8 M |
Long Term Debt |
7.73 M | 9.29 M | 205 M | 226 M | 260 M | 167 M | 135 M | 83.2 M | 124 M | 134 M | 215 M | 5.15 M | - |
Long Term Debt Current |
13 M | 11.6 M | 11.6 M | 9.03 M | 12 M | - | 11.9 M | 12 M | 11.5 M | 13.5 M | 12.6 M | - | 8.76 M |
Total Non Current Liabilities |
422 M | 392 M | 385 M | 426 M | 445 M | 371 M | 398 M | 412 M | 568 M | 349 M | 427 M | 34.2 M | 49.8 M |
Total Current Liabilities |
200 M | 213 M | 330 M | 375 M | 249 M | 288 M | 312 M | 263 M | 252 M | 83.1 M | 91.8 M | 52.4 M | 18.8 M |
Total Liabilities |
622 M | 606 M | 715 M | 802 M | 695 M | 660 M | 699 M | 675 M | 820 M | 432 M | 519 M | 86.6 M | 68.6 M |
Deferred Revenue |
- | - | 258 K | 15.8 M | 19.2 M | 63.5 M | 46.2 M | 73.4 M | 70.2 M | 4.18 M | 7.64 M | 1.52 M | - |
Retained Earnings |
-2.01 B | -1.82 B | -1.51 B | -1.48 B | -1.51 B | -1.2 B | -1.01 B | -730 M | -705 M | -675 M | -503 M | -389 M | -360 M |
Total Assets |
2.01 B | 2.17 B | 2.4 B | 2.47 B | 2.31 B | 2.45 B | 2.58 B | 2.77 B | 2.8 B | 1.27 B | 1.39 B | 290 M | 229 M |
Cash and Cash Equivalents |
95.9 M | 153 M | 135 M | 72.2 M | 85.5 M | 96.5 M | 91.5 M | 169 M | 194 M | 96.9 M | 186 M | 27.4 M | 71.5 M |
Book Value |
1.39 B | 1.56 B | 1.69 B | 1.67 B | 1.61 B | 1.79 B | 1.89 B | 2.09 B | 1.98 B | 836 M | 873 M | 203 M | 161 M |
Total Shareholders Equity |
1.39 B | 1.56 B | 1.69 B | 1.67 B | 1.61 B | 1.79 B | 1.84 B | 2.05 B | 1.98 B | 842 M | 876 M | 179 M | 161 M |
All numbers in USD currency
Quarterly Balance Sheet OPKO Health
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
3.53 M | 3.68 M | 4.04 M | 7.93 M | 8.5 M | 245 M | 9.29 M | 245 M | - | 230 M | 205 M | 1.67 M | 3.97 M | 3.32 M | 3.84 M | 4.01 M | 3.84 M | 3.84 M | 3.91 M | 4.09 M | 3.91 M | 3.91 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 1.57 M | 1.57 M | 1.57 M | 1.57 M | 717 K | 717 K | 717 K | 717 K | 2.52 M | 2.52 M | 2.52 M | 2.52 M | 2.43 M | 2.43 M | 2.43 M | 2.43 M | 3.27 M | 3.27 M | 3.27 M | 3.27 M | 5.15 M | 5.15 M | - | - | - | - | - | - |
Total Non Current Liabilities |
641 M | 365 M | 517 M | 412 M | 397 M | 395 M | 392 M | 328 M | - | 383 M | 385 M | 369 M | 375 M | 419 M | 426 M | 426 M | 426 M | 426 M | 445 M | 445 M | 445 M | 445 M | 371 M | 371 M | 371 M | 371 M | 434 M | 418 M | 418 M | 418 M | 480 M | 412 M | 412 M | 412 M | 567 M | 567 M | 567 M | 567 M | 349 M | 349 M | 349 M | 349 M | 427 M | 427 M | 427 M | 427 M | 34.2 M | 34.2 M | 34.2 M | 34.2 M | - | 2.15 M | 1.6 M | - |
Total Liabilities |
853 M | 585 M | 721 M | 612 M | 624 M | 618 M | 606 M | 596 M | - | 692 M | 715 M | 652 M | 679 M | 823 M | 802 M | 802 M | 802 M | 802 M | 695 M | 695 M | 695 M | 695 M | 660 M | 660 M | 660 M | 660 M | 746 M | 734 M | 734 M | 734 M | 720 M | 675 M | 675 M | 675 M | 819 M | 819 M | 819 M | 819 M | 432 M | 432 M | 432 M | 432 M | 519 M | 519 M | 519 M | 519 M | 86.6 M | 86.6 M | 86.6 M | 86.6 M | 44.2 M | 44.2 M | 44.2 M | 44.2 M |
Deferred Revenue |
- | - | - | - | - | - | - | 257 K | - | 258 K | 258 K | 3 M | 8.4 M | 15 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 63.5 M | 63.5 M | 63.5 M | 63.5 M | 56.9 M | 52.4 M | 75 M | 73.9 M | 50.2 M | 73.4 M | 73.4 M | 73.4 M | 70.2 M | 70.2 M | 70.2 M | 70.2 M | 4.18 M | 4.18 M | 4.18 M | 4.18 M | 7.64 M | 7.64 M | 7.64 M | 7.64 M | 1.52 M | 1.52 M | 1.52 M | 1.52 M | 530 K | 530 K | - | - |
Retained Earnings |
-2.08 B | -2.1 B | -2.09 B | -1.95 B | -1.86 B | -1.84 B | -1.82 B | -1.74 B | - | -1.55 B | -1.51 B | -1.44 B | -1.47 B | -1.45 B | -1.48 B | -1.48 B | -1.48 B | -1.48 B | -1.51 B | -1.51 B | -1.51 B | -1.51 B | -1.2 B | -1.2 B | -1.2 B | -1.2 B | -1.05 B | -1.04 B | -1.04 B | -1.04 B | -775 M | -730 M | -730 M | -730 M | -705 M | -705 M | -705 M | -705 M | -675 M | -675 M | -675 M | -675 M | -503 M | -503 M | -503 M | -503 M | -389 M | -389 M | -389 M | -389 M | -360 M | -360 M | -360 M | -360 M |
Total Assets |
2.26 B | 1.98 B | 1.97 B | 2.06 B | 2.16 B | 2.17 B | 2.17 B | 2.22 B | - | 2.31 B | 2.4 B | 2.42 B | 2.42 B | 2.52 B | 2.47 B | 2.47 B | 2.47 B | 2.47 B | 2.31 B | 2.31 B | 2.31 B | 2.31 B | 2.45 B | 2.45 B | 2.45 B | 2.45 B | 2.59 B | 2.59 B | 2.59 B | 2.59 B | 2.77 B | 2.77 B | 2.77 B | 2.77 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 1.27 B | 1.27 B | 1.27 B | 1.27 B | 1.39 B | 1.39 B | 1.39 B | 1.39 B | 290 M | 290 M | 290 M | 290 M | 229 M | 229 M | 229 M | 229 M |
Cash and Cash Equivalents |
400 M | 40.6 M | 75.6 M | 139 M | 108 M | 111 M | 153 M | 181 M | 210 M | 102 M | 135 M | 149 M | 65.8 M | 89.5 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 85.5 M | 85.5 M | 85.5 M | 85.5 M | 96.5 M | 96.5 M | 96.5 M | 96.5 M | 91.5 M | 91.5 M | 91.5 M | 91.5 M | 169 M | 169 M | 169 M | 169 M | 194 M | 194 M | 194 M | 194 M | 96.9 M | 96.9 M | 96.9 M | 96.9 M | 186 M | 186 M | 186 M | 186 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 71.5 M | 71.5 M | 71.5 M | 71.5 M |
Book Value |
1.4 B | 1.4 B | 1.25 B | 1.44 B | 1.54 B | 1.55 B | 1.56 B | 1.63 B | - | 1.61 B | 1.69 B | 1.77 B | 1.74 B | 1.7 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.61 B | 1.61 B | 1.61 B | 1.61 B | 1.79 B | 1.79 B | 1.79 B | 1.79 B | 1.84 B | 1.86 B | 1.86 B | 1.86 B | 2.05 B | 2.09 B | 2.09 B | 2.09 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B | 836 M | 836 M | 836 M | 836 M | 873 M | 873 M | 873 M | 873 M | 203 M | 203 M | 203 M | 203 M | 185 M | 185 M | 185 M | 185 M |
Total Shareholders Equity |
1.4 B | 1.4 B | 1.25 B | 1.44 B | 1.54 B | 1.55 B | 1.56 B | 1.63 B | 1.72 B | 1.61 B | 1.69 B | 1.77 B | 1.74 B | 1.7 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.61 B | 1.61 B | 1.61 B | 1.61 B | 1.79 B | 1.79 B | 1.79 B | 1.79 B | 1.84 B | 1.86 B | 1.86 B | 1.86 B | 2.05 B | 2.09 B | 2.09 B | 2.09 B | 2 B | 1.97 B | 835 M | 820 M | 842 M | 842 M | 842 M | 842 M | 876 M | 876 M | 876 M | 876 M | 179 M | 179 M | 179 M | 179 M | 161 M | 161 M | 161 M | 161 M |
All numbers in USD currency